Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

A whole genome study and identification of specific carcinogenic regions of the human papilloma viruses.

Diallo AB, Badescu D, Blanchette M, Makarenkov V.

J Comput Biol. 2009 Oct;16(10):1461-73. doi: 10.1089/cmb.2009.0091.

PMID:
19754274
2.

Human papillomaviruses: genetic basis of carcinogenicity.

Burk RD, Chen Z, Van Doorslaer K.

Public Health Genomics. 2009;12(5-6):281-90. doi: 10.1159/000214919. Epub 2009 Aug 11. Review.

3.

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline.

Schiffman M, Clifford G, Buonaguro FM.

Infect Agent Cancer. 2009 Jun 1;4:8. doi: 10.1186/1750-9378-4-8.

4.

Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited.

Koshiol J, Hildesheim A, Gonzalez P, Bratti MC, Porras C, Schiffman M, Herrero R, Rodriguez AC, Wacholder S, Yeager M, Chanock SJ, Burk RD, Wang SS.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1631-7. doi: 10.1158/1055-9965.EPI-08-0830.

5.

A review of human carcinogens--Part B: biological agents.

Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group..

Lancet Oncol. 2009 Apr;10(4):321-2. No abstract available.

PMID:
19350698
6.

Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97.

Chen Z, DeSalle R, Schiffman M, Herrero R, Burk RD.

J Virol. 2009 Feb;83(3):1443-55. doi: 10.1128/JVI.02068-08. Epub 2008 Nov 26.

7.

Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer.

de Araujo Souza PS, Maciag PC, Ribeiro KB, Petzl-Erler ML, Franco EL, Villa LL.

BMC Cancer. 2008 Aug 22;8:246. doi: 10.1186/1471-2407-8-246.

8.

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

Rodríguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, Solomon D, Burk R; Proyecto Epidemiológico Guanacaste Group..

J Natl Cancer Inst. 2008 Apr 2;100(7):513-7. doi: 10.1093/jnci/djn044. Epub 2008 Mar 25.

9.

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.

Carreon JD, Sherman ME, Guillén D, Solomon D, Herrero R, Jerónimo J, Wacholder S, Rodríguez AC, Morales J, Hutchinson M, Burk RD, Schiffman M.

Int J Gynecol Pathol. 2007 Oct;26(4):441-6.

PMID:
17885496
10.

Human papillomavirus and cervical cancer.

Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S.

Lancet. 2007 Sep 8;370(9590):890-907. Review.

PMID:
17826171
11.

A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.

Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM; ALTS Group..

J Infect Dis. 2007 Jun 1;195(11):1582-9. Epub 2007 Apr 16.

PMID:
17471427
12.

Human papillomavirus subtypes are not uncommon.

Hazard K, Andersson K, Dillner J, Forslund O.

Virology. 2007 May 25;362(1):6-9. Epub 2007 Mar 28.

13.
14.

Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

Kovacic MB, Castle PE, Herrero R, Schiffman M, Sherman ME, Wacholder S, Rodriguez AC, Hutchinson ML, Bratti MC, Hildesheim A, Morales J, Alfaro M, Burk RD.

Cancer Res. 2006 Oct 15;66(20):10112-9.

15.

Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix.

Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, Tellier P, Simao J, Matlashewski G, Roger M, Franco EL, Coutlée F.

J Infect Dis. 2006 Oct 1;194(7):886-94. Epub 2006 Aug 30.

PMID:
16960775
16.

Human papillomavirus type 16 and 18 variants: race-related distribution and persistence.

Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, Koutsky LA.

J Natl Cancer Inst. 2006 Aug 2;98(15):1045-52.

PMID:
16882941
17.

Genome variation of human papillomavirus types: phylogenetic and medical implications.

Bernard HU, Calleja-Macias IE, Dunn ST.

Int J Cancer. 2006 Mar 1;118(5):1071-6. Review.

18.

Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses.

Narechania A, Chen Z, DeSalle R, Burk RD.

J Virol. 2005 Dec;79(24):15503-10.

19.

Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16.

Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Chu TY, Cubie HA, Cuschieri K, von Knebel-Doeberitz M, Martins CR, Sanchez GI, Bosch FX, Munoz N, Bernard HU.

J Virol. 2005 Nov;79(21):13630-40.

20.

Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women.

Schlecht NF, Burk RD, Palefsky JM, Minkoff H, Xue X, Massad LS, Bacon M, Levine AM, Anastos K, Gange SJ, Watts DH, Da Costa MM, Chen Z, Bang JY, Fazzari M, Hall C, Strickler HD.

J Gen Virol. 2005 Oct;86(Pt 10):2709-20.

PMID:
16186224

Supplemental Content

Support Center